Search Results
Jan 13, 2026, 03:00 ET Save Ohio Parks and environmental advocates warn against expanding frack leases under Ohio state parks and public lands
expressionless members of the Ohio Oil and Gas Land Management Commissioners asked no questions and unanimously voted 4-0 to award Grenadier Energy III LLC of The Woodlands, Texas rights to frack 171 acres of Leesville Wildlife Area in Carroll County. Commissioners accepted $6,000 per acre, or $1 M,
More news about: Save Ohio Parks
Jan 13, 2026, 01:47 ET Bitmine 沉浸技術（BMNR）宣佈 ETH（以太幣）持倉達到 416.8 萬枚代幣，加密貨幣總額和現金總持有量達 140 億美元
Bitmine 是美國交易量排名第 67 的股票，每日交易額達 13 億美元（5 天平均值）Bitmine 仍然得到頂級機構投資者（包括 ARK 的 Cathie Wood、MOZAYYX、Founders Fund、Bill Miller III、Pantera、Kraken、DCG、Galaxy Digital 和個人投資者 Thomas "Tom" Lee）支持，從而支援 Bitmine 收購 5% ETH 的目標拉斯維加斯2026年1月13日
More news about: BitMine Immersion Technologies, Inc.
Jan 12, 2026, 20:49 ET Vistra Prices Private Offering of $2.250 Billion of Senior Secured Notes
the Company of Cogentrix Energy (the "Cogentrix Transaction"), (ii) for general corporate purposes, including to repay existing indebtedness and/or (iii) to pay fees and expenses related to the Offering.The Offering is expected to close on January 22, 2026, subject to customary closing conditions.The
More news about: Vistra Corp
Jan 12, 2026, 19:54 ET Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
pimicotinib is supported by the robust efficacy and safety outcomes from the global, multicenter, randomized, double-blind, placebo-controlled Phase III MANEUVER trial. In the trial, TGCT patients who received once-daily oral pimicotinib achieved a statistically significant improvement in the primary
More news about: Abbisko
Jan 12, 2026, 17:31 ET Persistent Corneal Edema Market to Show Impressive Growth at a CAGR of 21.8% During the Forecast Period (2025-2034) | DelveInsight
primary, secondary, and exploratory endpoints at 12 months in the Phase I/II CLARA trial, supporting advancement of the high-dose regimen into a Phase III trial planned for early 2026, along with parallel clinical development planning in the EU.In March 2025, Alcon acquired a majority interest
More news about: DelveInsight Business Research, LLP
Jan 12, 2026, 17:14 ET Else Nutrition Announces Results from Annual General Meeting of Shareholders
dated December 18, 2022, as amended and restated February 13, 2025, as more particularly described in the Circular; (iii) the issuance of common shares of the Company to Lind Global Fund III, LP, pursuant to a convertible security funding agreement dated November 23, 2025, as more particularly described
More news about: Else Nutrition Holdings Inc.
Jan 12, 2026, 16:00 ET ZIEGLER CLOSES $162,860,000 FINANCING FOR PRESBYTERIAN LIVING - THE MOORINGS (IL)
$63,870,000 Series 2025A fixed rate bonds, (ii) $22,300,000 Series 2025B-2 TEMPS-50SM (expected to be repaid at 50% occupancy of the Project), (iii) $15,600,000 Series 2025B-1 TEMPS-85SM (expected to be repaid at 85% occupancy of the Project), and (iv) $61,090,000 Series 2025C bank drawdown
More news about: Ziegler
Jan 12, 2026, 13:19 ET Bitmine Immersion Technologies (BMNR) Công Bố Nắm Giữ 4,168 Triệu Token ETH và Tổng Cộng 14 Tỷ USD Tiền Mã Hóa và Tiền Mặt
Bitmine hiện vẫn được hỗ trợ bởi một nhóm các nhà đầu tư tổ chức hàng đầu như Cathie Wood của ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital và nhà đầu tư cá nhân Thomas "Tom" Lee nhằm giúp BitMine đạt mục tiêu sở hữu 5% ETHLAS
More news about: BitMine Immersion Technologies, Inc.
Jan 12, 2026, 13:09 ET Bitmine Immersion Technologies (BMNR) annuncia che le partecipazioni in ETH hanno raggiunto 4,168 milioni di token e che le partecipazioni totali in criptovalute e contanti ammontano a 14,0 miliardi di dollari
Bitmine continua a essere supportata da un gruppo di investitori istituzionali di alto livello: Cathie Wood di ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore personale Thomas "Tom" Lee, per conseguire l'obiettivo di acquisire il 5% di ETH
More news about: BitMine Immersion Technologies, Inc.
Jan 12, 2026, 12:00 ET The Pines at Shrub Oak Marks One-Year Anniversary, Reporting Strong Outcomes for Neurodiverse Youth Requiring Intensive Psychiatric Support
support.Shrub Oak International School is accredited by:The National Independent Private Schools Association (NIPSA), Level III Therapeutic Certification, Academic Accreditation, with an Autism Endorsement;The Middle States Association Commission on
More news about: Shrub Oak International School
Jan 12, 2026, 10:02 ET Bitmine anuncia que sus tenencias de ETH alcanzan los 4,168 millones de tokens
Bitmine cuenta con el respaldo de un destacado grupo de inversores institucionales, entre ellos Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversor personal Thomas "Tom" Lee, para apoyar el objetivo de Bitmine de adquirir el 5 % de ETH
More news about: BitMine Immersion Technologies, Inc.
Jan 12, 2026, 10:00 ET ALDI US Doubles Down on Growth in 2026 with Plans to Open 180 New Stores, Announces Plans for Continued Westward Expansion into Colorado
ALDI Multimedia Center. i According to ALDI proprietary dataii According to ALDI proprietary dataiii According to the
More news about: ALDI
Jan 12, 2026, 09:15 ET StockX's Current Culture Index Highlights 2025's Biggest Winners, Reveals Predictions for 2026
Canon PowerShot G7 X Mark III.Scarcity Continues to Fuel Success in Accessories
More news about: StockX
Jan 12, 2026, 09:00 ET BURFORD CAPITAL ANNOUNCES PRIVATE OFFERING OF SENIOR NOTES
"Insurance Distribution Directive"), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a "qualified investor" as defined in Regulation (EU) No. 2017/1129 (as amended, the "Prospectus Regulation"). No key information document required
More news about: Burford Capital Limited
Jan 12, 2026, 08:42 ET Vistra Announces Private Offering of Senior Secured Notes
the Company of Cogentrix Energy (the "Cogentrix Transaction"), (ii) for general corporate purposes, including to repay existing indebtedness and/or (iii) to pay fees and expenses related to the Offering.The Notes will not be registered under the Securities Act or the securities laws of any state
More news about: Vistra Corp
Jan 12, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.168 Million Tokens, and Total Crypto and Total Cash Holdings of $14.0 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETH
More news about: BitMine Immersion Technologies, Inc.
Jan 12, 2026, 08:30 ET IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales
breast cancer, post-market activity, and recommendations from professional medical associations. ProSense® currently has reimbursement under the CPT III code which increased to $4,049 effective January 2026.Terumo, our distributor in Japan, is expected to submit a request for breast cancer clearance
More news about: IceCure Medical
Jan 12, 2026, 08:30 ET Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.168 Million Tokens, and Total Crypto and Total Cash Holdings of $14.0 Billion
Bitmine remains supported by a premier group of institutional investors including ARK's Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas "Tom" Lee to support Bitmine's goal of acquiring 5% of ETHLAS
More news about: BitMine Immersion Technologies, Inc.
Jan 12, 2026, 08:00 ET Petco Announces Launch of Debt Refinancing Transaction; Reaffirms Fourth Quarter and Full Fiscal Year 2025 Outlook
from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments;
More news about: Petco - Investor Relations
Jan 12, 2026, 07:01 ET CES 2026: Roborock prezentuje pierwszego na świecie robota sprzątającego zdolnego samodzielnie wjeżdżać po schodach i ogłasza strategiczne partnerstwo z klubem piłkarskim Real Madryt
3.0 – pierwszy w branży masowo produkowany system unoszonego podwozia z kontrolą trzech kół, wprowadzony w III kwartale 2024 r. Dynamiczne czyszczenie dywanów zostało oficjalnie zaprezentowane w III kwartale 2025 r.9. Na podstawie wewnętrznych testów producenta. Funkcja wymaga ręcznego włączenia
More news about: Roborock
Jan 12, 2026, 07:00 ET Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis
development company focused on developing innovative therapies for immune and inflammatory diseases, today announced positive topline results from its Phase III clinical trial evaluating zemprocitinib (LNK01001) in patients with moderate to severe active rheumatoid arthritis (RA). The study met its primary and
More news about: Lynk Pharmaceuticals Co., Ltd.
Jan 12, 2026, 07:00 ET Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Depressive Disorder (MDD) who failed to achieve satisfactory improvement from at least one previous antidepressant medication. The approval under the Class III Premarket Approval (PMA) pathway was supported by clinical evidence from the
More news about: Neurolief
Jan 12, 2026, 07:00 ET Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Depressive Disorder (MDD) who failed to achieve satisfactory improvement from at least one previous antidepressant medication. The approval under the Class III Premarket Approval (PMA) pathway was supported by clinical evidence from the
More news about: Neurolief
Jan 12, 2026, 07:00 ET Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026
multiple myeloma after at least one prior therapy; (ii) in combination with dexamethasone in adult patients with heavily pre-treated multiple myeloma; and (iii) under accelerated approval in adult patients with diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from follicular lymphoma, after at
More news about: Karyopharm Therapeutics Inc.
Jan 12, 2026, 00:26 ET ADI Foundation and Finstreet Partner with BlockBooster to Lead Ecosystem Development for Regulated Tokenized Products
structuring, tokenization and listing of private credit, private equity and technology-related assets suitable for institutional investors; and(iii) Ecosystem development, including potential collaboration on investments, supporting infrastructure, asset onboarding and coordinated go-to-market
More news about: ADI Foundation